A $100 share buys a new fixed-dose combination drug that includes artemisinin, a Chinese herb.
From the theepochtimes.com
The medicine, developed by a Brazilian pharmaceutical company and a non-profit drug development organization, is a new fixed-dose combination of two existing malaria medications.